Granulomatous lung disease occurring during etanercept treatment
Open Access
- 4 August 2005
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 53 (4) , 618-620
- https://doi.org/10.1002/art.21336
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Etanercept plus Standard Therapy for Wegener's GranulomatosisNew England Journal of Medicine, 2005
- Pulmonary granulomas after tumour necrosis factor alpha antagonist therapyThorax, 2003
- Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-? therapyJournal of the American Academy of Dermatology, 2003
- Transmembrane TNF Induces an Efficient Cell-Mediated Immunity and Resistance toMycobacterium bovisBacillus Calmette-Guérin Infection in the Absence of Secreted TNF and Lymphotoxin-αThe Journal of Immunology, 2002
- Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trialThe Lancet, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Statement on SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- Pulmonary SarcoidosisNew England Journal of Medicine, 1981